#therapy

Collection of therapy news, found 117 news.

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

-            - First Randomized Controlled Trial to Show That Basal Plus ...

Synthes and Lilly Sign Development and Collaboration Agreement

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

One in five people with diabetes miss up to 15 working hours per month due to low blood sugar

-    Nearly one in five people with diabetes are regularly unable to attend a full day at work due to ...

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

-        - NOT INTENDED FOR US MEDIA    - Ingenol Mebutate is an ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Procoralan(R) Significantly Improves Quality of Life as Well as Survival

-        Results of a new analysis from the largest-ever morbi-mortality study of ...

The Trial of Indonesia Interfaith Spiritual Anand Krishna

The trial against Indonesia Interfaith Spiritual Activist Anand Krishna, who allegedly violating Article 290 and 294 ...

RI calls on int`l community to cut narcotics demand

Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...

Polyplus-Transfection Raises EUR 2.5 Million in Latest Funding Round

-        - The Additional Funds Will Enable the Company to Expand its Therapeutic ...

RI begins exporting eaglewood to China directly

Jakarta (ANTARA News)  - Indonesia ihas begun exporting aglewood directly to China after having always done so ...

Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator

-     Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new ...